What is the latest market price of a box of erlotinib?

Erlotinib (Erlotinib) is a tyrosine kinase inhibitor targeting the epidermal growth factor receptor (EGFR). It is mainly used to treat EGFR mutation-positive non-small cell lung cancer (NSCLC). This drug inhibits the proliferation and metastasis of tumor cells by blocking the EGFR signaling pathway, thereby achieving the effect of inhibiting tumor growth. The application of erlotinib has achieved clinical results, especially in patients with newly treated and recurrent non-small cell lung cancer. It can improve the progression-free survival (PFS) and overall survival (OS) of patients, and the side effects are relatively controllable, making it an important treatment option for many patients.

With the gradual popularity of erlotinib in the domestic market, the drug has been included in the scope of medical insurance, greatly reducing the financial burden on patients. Patients can purchase it at hospital pharmacies or other compliant channels, and the market price ranges from tens of yuan to six or seven hundred yuan. Changes in this price range are mainly subject to factors such as drug specifications, dosage forms, and regional differences. Therefore, it is recommended that patients consult the local hospital pharmacy for specific medical insurance reimbursement prices to obtain the most accurate information. In addition, it is worth noting that medical insurance policies in different regions may differ, which may affect patients’ out-of-pocket expenses.

In the international market, erlotinib also has multiple versions, including original drugs and generic drugs. Among them, generic drugs produced in India are favored by many patients because of their relatively cheap prices. Generally, the price of generic erlotinib in India is about RMB 800, which is a more affordable option for some patients with poor financial conditions. Although the ingredients of original drugs and generic drugs are basically the same, due to possible differences in production processes, quality control, etc., patients should take the source and reliability of the drug into consideration when choosing.

Reference materials:https://en.wikipedia.org/wiki/Erlotinib